Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1508 - Measurable Residual Disease in Chronic Lymphocytic Leukemia (CLL) in Clinical Practice: A Single-Center Report Over the Years 2018–2024

    Primary Author / Presenter(s)

  • JM

    Jana Mihályová, MD

    physician
    Department of Hematooncology, University Hospital
    Ostrava, Czech Republic

    • Co-Author(s)

  • KK

    Kamila Kutějová

    Department of Flow Cytometry, Spadia Lab plc, Ostrava, Czech Republic
    Ostrava, Moravskoslezsky kraj, Czech Republic

  • IK

    Ingrid Kováčová

    Department of Hematooncology, University hospital Ostrava
    Ostrava, Moravskoslezsky kraj, Czech Republic

  • JZ

    Jana Zuchnická, MD

    Department of Hematooncology, University Hospital, Ostrava, Czech Republic
    Ostrava, Czech Republic

  • KL

    Klára Lančová

    Department of Hematooncology, University hospital Ostrava
    Ostrava, Moravskoslezsky kraj, Czech Republic

  • MH

    Michaela Horňáková

    Department of Hematooncology, University hospital Ostrava
    Ostrava, Moravskoslezsky kraj, Czech Republic

  • VL

    Václav Lipka

    Department of Hematooncology, University hospital Ostrava
    Ostrava, Moravskoslezsky kraj, Czech Republic

  • VK

    Viktor Kubala

    Department of Flow Cytometry, Spadia Lab plc, Ostrava
    Ostrava, Moravskoslezsky kraj, Czech Republic

  • TJ

    Tomáš Jelínek

    Department of Hematooncology, University hospital Ostrava, Faculty of Medicine, University of Ostrava
    Ostrava, Moravskoslezsky kraj, Czech Republic

  • RH

    Roman Hájek

    Department of Hematooncology, University hospital Ostrava, Faculty of Medicine, University of Ostrava
    Ostrava, Moravskoslezsky kraj, Czech Republic